Published in Lab Business Week, November 12th, 2006
The 10-page report by Dutton senior analyst Stephen Handley is available at www.jmdutton.com as well as from First Call, Bloomberg, Zacks, Reuters, Knobias, and other leading financial portals.
AlphaRX is a clinical stage pharmaceutical company engaged in developing novel formulations of existing drugs that are insoluble or poorly soluble in water. The company achieved several significant milestones in fiscal 2006, ended September 30, and prospects for the current fiscal year are encouraging. Specifically, we anticipate a $3 million milestone payment once...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.